| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33652387_HAS_TOPIC_C0008976> <https://research.tib.eu/covid-19/entity/33652387_HAS_TOPIC_C0011000> <https://research.tib.eu/covid-19/entity/33652387_HAS_TOPIC_C0015179> <https://research.tib.eu/covid-19/entity/33652387_HAS_TOPIC_C0015320> <https://research.tib.eu/covid-19/entity/33652387_HAS_TOPIC_C0022886> <https://research.tib.eu/covid-19/entity/33652387_HAS_TOPIC_C0024908> <https://research.tib.eu/covid-19/entity/33652387_HAS_TOPIC_C0033210> <https://research.tib.eu/covid-19/entity/33652387_HAS_TOPIC_C0035168> <https://research.tib.eu/covid-19/entity/33652387_HAS_TOPIC_C0035170> <https://research.tib.eu/covid-19/entity/33652387_HAS_TOPIC_C0035171> <https://research.tib.eu/covid-19/entity/33652387_HAS_TOPIC_C0035174> <https://research.tib.eu/covid-19/entity/33652387_HAS_TOPIC_C0035177> <https://research.tib.eu/covid-19/entity/33652387_HAS_TOPIC_C0036449> <https://research.tib.eu/covid-19/entity/33652387_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33652387_HAS_TOPIC_C0086912> <https://research.tib.eu/covid-19/entity/33652387_HAS_TOPIC_C0242481> <https://research.tib.eu/covid-19/entity/33652387_HAS_TOPIC_C0242484> <https://research.tib.eu/covid-19/entity/33652387_HAS_TOPIC_C0376368> <https://research.tib.eu/covid-19/entity/33652387_HAS_TOPIC_C0524590> <https://research.tib.eu/covid-19/entity/33652387_HAS_TOPIC_C0524591> <https://research.tib.eu/covid-19/entity/33652387_HAS_TOPIC_C0524592> <https://research.tib.eu/covid-19/entity/33652387_HAS_TOPIC_C0600216> <https://research.tib.eu/covid-19/entity/33652387_HAS_TOPIC_C1615608> <https://research.tib.eu/covid-19/entity/33652387_HAS_TOPIC_C4046011> <https://research.tib.eu/covid-19/entity/33652387_HAS_TOPIC_C4505431> <https://research.tib.eu/covid-19/entity/33652387_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33652387_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Department of Pharmaceutical and Pharmacological Sciences, Clinical Pharmacology and Pharmacotherapy, KU Leuven Leuven Belgium.\', \'Centre for IT & IP Law (CiTiP), KU Leuven Leuven Belgium.\', \'European Organisation for Research and Treatment of Cancer Brussels Belgium.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Deleersnijder_Angelique> <https://research.tib.eu/covid-19/entity/Huys_Isabelle> <https://research.tib.eu/covid-19/entity/Lalova_Teodora> <https://research.tib.eu/covid-19/entity/Negrouk_Anastassia> <https://research.tib.eu/covid-19/entity/Valcke_Peggy>
?:doi	10.1163/15718093-BJA10031
?:doi	<https://research.tib.eu/covid-19/entity/10.1163/15718093-BJA10031>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	European journal of health law
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33652387>
?:pmid	<https://research.tib.eu/covid-19/entity/33652387>
?:pmid	33652387
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	0.23
?:rankingScore_hIndex	18
?:title	Conducting Non-COVID-19 Clinical Trials during the Pandemic: Can Today\'s Learning Impact Framework Efficiency?
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2020

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33652387>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33652387>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all